Brazil's Bio-Manguinhos Invests More than $600 Million in Biosimilar New Final Processing Center

---

Industrial Info is tracking a grassroot biosimilar complex, named New Final Processing Center, that Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos is constructing in Santa Cruz, Rio de Janeiro, Brazil. The facility will include all needed production areas, from the raw material storage to fill and finish, packaging and final product storage, along with laboratories, utilities and administrative areas, to form the Health Biotechnology Industrial Complex (CIBS).

The complex is expected to occupy 2,152,782 square feet, and aims to start production of 120 million of vaccine vials against meningitis, hepatitis, and triple bacterial infection once completed in 2023.

Industrial Info's also is tracking 16 pharma-bio fill and finish projects in Brazil valued at $917.7 million. Click here for a list, and see graph below for a breakdown by project type.